| 1 |
2024 |
Kazi N Islam, Rahib K Islam, Victoria T Tong, M Zaid Shami, Kaitlyn E Allen, Jared R Brodtmann, Jordan A Book. Obesity Medications and Their Impact on Cardiovascular Health: A Narrative Review, Cureus. 2024;
https://doi.org/10.7759/cureus.71875 |
| 2 |
2025 |
Ahmed Y. Azzam, Muhammed Amir Essibayi, Dhrumil Vaishnav, Mohammed A. Azab, Mahmoud M. Morsy, Osman Elamin, Adam Elswedy, Oday Atallah, Hana J. Abukhadijah, Adam A. Dmytriw, Amanda Baker, Deepak Khatri, Neil Haranhalli, David J. Altschul. Liraglutide for idiopathic intracranial hypertension: a real‐world propensity score‐matched study, Annals of Clinical and Translational Neurology. 2025; acn3.52300.
https://doi.org/10.1002/acn3.52300 |
| 3 |
2025 |
Pranav Vasu, Emily A. Dorairaj, Robert N. Weinreb, Alex S. Huang, Syril K. Dorairaj. Risk of Glaucoma in Patients without Diabetes Using a Glucagon-Like Peptide 1 Receptor Agonist, Ophthalmology. 2025;
https://doi.org/10.1016/j.ophtha.2025.02.011 |
| 4 |
2025 |
Ahmed Y. Azzam, Muhammed Amir Essibayi, Nathan Farkas, Mohammed A. Azab, Mahmoud M. Morsy, Osman Elamin, Adam Elswedy, Ahmed Saad Al Zomia, Hammam A. Alotaibi, Ahmed Alamoud, Oday Atallah, Hana J. Abukhadijah, Adam A. Dmytriw, Amanda Baker, Deepak Khatri, Neil Haranhalli, David J. Altschul. Efficacy of Tirzepatide Dual GIP/GLP‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study, Endocrinology, Diabetes & Metabolism. 2025; 8: e70019.
https://doi.org/10.1002/edm2.70019 |
| 5 |
2025 |
Sing-Hua Tsou, Kai-Shin Luo, Chien-Ning Huang, Edy Kornelius, I-Ting Cheng, Hui-Chih Hung, Yu-Chien Hung, Chih-Li Lin, Min-Yen Hsu. Liraglutide Attenuates FFA-Induced Retinal Pigment Epithelium Dysfunction via AMPK Activation and Lipid Homeostasis Regulation in ARPE-19 Cells, International Journal of Molecular Sciences. 2025; 26: 3704.
https://doi.org/10.3390/ijms26083704 |
